39 Recruiting Breast Cancer Clinical Trials in Boston
Explore active breast cancer research studies enrolling participants across Massachusetts near Boston. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Recruiting Breast Cancer Studies
NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer
📍 Massachusetts General Hospital. — Boston, Massachusetts
View Study & Checklist ➔The Preoperative Health & Body Study
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔A Pilot Study of Tomographic Optical Breast Imaging (DBT-TOBI) to Monitor Response to Neoadjuvant Therapy
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔YES Study - Newly Diagnosed/Metastatic Intervention
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Olaparib + Sapacitabine in BRCA Mutant Breast Cancer
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Dance Study for Post-surgical Pain in Breast Cancer Survivors
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Taking AIM at Breast Cancer
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer
📍 Research Site — Boston, Massachusetts
View Study & Checklist ➔DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Prospective Study of the Prosigna Assay on Neoadjuvant Clinical Decision-making in Women With HR+/Her2- Breast Cancer
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Ultrahypofractionation and Normal Tissue Toxicity
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔Physical Activity, Proliferation and Immune Markers in Benign Breast Tissue
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Onvansertib + Paclitaxel In TNBC
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Efficacy and Safety of 500mg of Fulvestrant
📍 Massachusetts General Hosptial — Boston, Massachusetts
View Study & Checklist ➔GDF-15 and Its Relationship With Treatment-related ADverse Events in Breast Cancer
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔Wearable Ultrasound Patch for Breast Imaging
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Early Intervention
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔Supporting Health Including Endocrine Treatment for Long Duration
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔VS-6766+Abema+Fulv in Met HR+/HER- BC
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔Oncoplastic Surgery Outcomes Database
📍 Tufts Medical Center — Boston, Massachusetts
View Study & Checklist ➔Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO Study
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Strength After Breast Cancer
📍 MGH Institute of Health Professions — Boston, Massachusetts
View Study & Checklist ➔Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔Refining Local-Regional Therapy for IBC
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔The COMPASSION Study
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔